BioXcel Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript
Great. Welcome, everyone, and welcome, especially to the team from BioXcel Therapeutics. Today, we have Vimal Mehta, CEO; Rob Risinger, CMO; and then we've got Matt Wiley, Chief Commercial Officer. So thanks to all of you for joining, and thanks to everyone who's joining us here and on the webcast.
Questions & Answers
Maybe just to start, could you level set with a brief overview of the company with perhaps a particular focus on what you see as key value drivers over the next 12 to 24 months?
Great. Thank you, Corinne, for hosting us, and good afternoon, everyone. BioXcel Therapeutics is a biopharmaceutical company developing innovative medicines in neuroscience and immuno-oncology using artificial intelligence-based platform.
In terms of where we are, we've been now, like a public
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |